This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Prokinecitine in Acute Myocardial Infarction (Prok-Idm)

This study is currently recruiting participants.
See Contacts and Locations
Verified September 2017 by University Hospital, Strasbourg, France
Sponsor:
Information provided by (Responsible Party):
University Hospital, Strasbourg, France
ClinicalTrials.gov Identifier:
NCT02021487
First received: December 19, 2013
Last updated: September 7, 2017
Last verified: September 2017
December 19, 2013
September 7, 2017
November 2013
November 2019   (Final data collection date for primary outcome measure)
Infarct size by MRI necrotic myocardial mass [ Time Frame: 7 days ]
Infarct size by MRI necrotic myocardial mass
Same as current
Complete list of historical versions of study NCT02021487 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Prokinecitine in Acute Myocardial Infarction
Pilot Study Prok-Idm: Interest of Dosage of Prokinecitine in Acute Myocardial Infarction
The study aims to investigate the presence of a substance in the blood called prokinecitine, which is released by the heart when a heart attack occurs. Several venous blood samples at the arm are withdrawn at admission, H6, H12, H24, H48 and H72 in order to measure the concentration of this substance in the blood. The usefulness of this new blood marker is going to be determsined to seek if it would be of help to better diagnose or estimate the gravity of heart infarction after a heart attack.
Not Provided
Observational
Observational Model: Case-Control
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients with acute St elevation myocardial infarction of less than 6 hours
ST Elevatation Myocardial Infarction (STEMI)
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
200
November 2019
November 2019   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients with acute St elevation myocardial infarction of less than 6 hours
  • Age>18 y/o

Exclusion Criteria:

  • Previous myocardial infarction
  • LBB, RBB
  • Renal Insuffiency MDRD<30 mL/min
  • Patient with Pace-Maker or ICD.
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact: Patrick OHLMANN, MD 03 69 55 09 53 ext 0033 patrick.ohlmann@chru-strasbourg.fr
France
 
 
NCT02021487
5515
No
Not Provided
Not Provided
University Hospital, Strasbourg, France
University Hospital, Strasbourg, France
Not Provided
Principal Investigator: Patrick OHLMANN, MD University Hospital, Strasbourg, France
University Hospital, Strasbourg, France
September 2017

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP